Gregory W Mattingly
9PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 20, 2025
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia.Leslie Citrome, Christoph U Correll, Andrew J Cutler
|Jan 17, 2025
Esketamine nasal spray versus quetiapine XR in adults with treatment-resistant depression: a secondary analysis of the ESCAPE-TRD randomized clinical trial.Roger S McIntyre, Gregory Mattingly, Yordan Godinov
|Jun 21, 2024
Are all ADHD medications created equal? Exploring the differences that enable evening dosing.Gregory W Mattingly, Julie A Carbray, Perry Roy
|May 20, 2024
Expert consensus statement for telepsychiatry and attention-deficit hyperactivity disorder.Jennifer Hong, Gregory W Mattingly, Julie A Carbray
|Jun 26, 2023
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder.Andrew J Cutler, Gregory W Mattingly, Vladimir Maletic
|Mar 08, 2023
Long-term safety and efficacy, including anhedonia, of vortioxetine for major depressive disorder: findings from two open-label studies.Gregory W Mattingly, Oscar Necking, Simon Nitschky Schmidt
Pageof 2
Frequent Collaborators
2 joint publications
Roger S McIntyre
1 joint publications
Gin S Malhi
1 joint publications
Erica Bell
1 joint publications
M Janelle Cambron-Mellott
1 joint publications
Jaromir Mikl
1 joint publications
Joana E Matos
1 joint publications
Jennifer G Erensen
1 joint publications
Kathleen Beusterien
1 joint publications
Marc J Cataldo
1 joint publications
Bernadette Hallissey
